-
Aktis Oncology Announces Pricing of its Upsized Initial Public Offering
09 Jan 2026 01:48 GMT
… of common stock at the initial public offering price, less underwriting discounts and … satisfaction of customary closing conditions. J.P. Morgan, BofA Securities, Leerink Partners and … available, may be obtained from: J.P. Morgan Securities LLC, c/o …
-
J.P. Morgan Report: Obesity & Diabetes Dealmaking Set a New Record in 2025
08 Jan 2026 03:43 GMT
… than the prior year, J.P. Morgan said these transactions generated … China-based biotech companies. J.P. Morgan counted 16 of these … the bank said. J.P. Morgan counted just nine IPOs that raised $1 … multi-billion-dollar transactions, J.P. Morgan said. A total of …
-
The IPO Buzz: Aktis Oncology (AKTS) Prices IPO at $18 – Top of Range – 1st Big IPO of 2026
09 Jan 2026 05:10 GMT
… cap of $945.5 million.
J.P. Morgan, BofA Securities, Leerink Partners … runners.
Aktis Oncology upsized its IPO by 50 percent yesterday – … check the IPO Calendar and the individual IPO Profile found on … see what time the NASDAQ IPOs are expected to trade, …
-
Why Wall Street Bankers Citi, JP Morgan Stepping Away From $1.4 Billion SBI Funds IPO
07 Jan 2026 10:54 GMT
While some international banks stepped aside, a strong roster of Indian financial institutions has been appointed to manage the offering. Kotak Mahindra Capital Co., Axis Bank Ltd., SBI Capital Markets Ltd., Motilal Oswal Investment Advisors Ltd., ICICI …
-
JP Morgan banker: Global pharma is hunting Asia -- partnerships now decide winners
07 Jan 2026 02:18 GMT
… San Francisco as the J.P. Morgan Healthcare Conference, which will … Healthcare Investment Banking at J.P. Morgan, provided a comprehensive outlook … is recovering with renewed IPO activity, the Asia-Pacific … a boom in healthcare IPOs -- over 25 healthcare …
-
The IPO Buzz: Aktis Oncology (AKTS Proposed) Upsizes IPO by 50 Percent to Raise $300 Million
07 Jan 2026 15:22 GMT
… Oncology (AKTS Proposed) upsized its IPO by 50 percent – by … $17.00 mid-point price.
J.P. Morgan, BofA Securities, Leerink Partners and … please check the IPO Calendar and the individual IPO Profile found on … see what time the NASDAQ IPOs are expected to trade, …
-
Aktis Oncology secures Lilly as anchor investor for upsized US IPO
07 Jan 2026 15:06 GMT
… 4 million in its upsized initial public offering, signaling strong investor demand … Lilly to anchor the IPO, with the pharma giant … Street is expecting biotech IPOs to rebound in 2026 … the trading symbol “AKTS.”
J.P. Morgan, BofA Securities, Leerink Partners …
-
WBD rejects Paramount Skydance bid, Strategy pops, Discord IPO
07 Jan 2026 15:31 GMT
… reportedly filed confidentially for an IPO. Bloomberg News is reporting the … working with Goldman Sachs and JP Morgan for that listing. Discord has …
-
Aktis Oncology targets up to $945 million valuation in upsized US IPO
07 Jan 2026 13:44 GMT
… .4 million in its upsized initial public offering, underscoring strong investor demand for … under the trading symbol “AKTS.”
J.P. Morgan, BofA Securities, Leerink Partners and …
-
There are ways to make billion dollars
09 Jan 2026 16:44 GMT
… big investors.
Adam Neumann conned J.P.Morgan, SoftBank, and other investors to … conflicts of interest, WeWork’s initial public offering fell apart, and the company …